Thyroid hormones strongly affect blood sugar through several pathways — gastric emptying, insulin clearance, hepatic glucose production, and peripheral glucose uptake. Hypothyroidism tends to cause unexplained hypoglycemia and lower insulin needs; hyperthyroidism causes hyperglycemia and raises insulin requirements by 30 to 50 percent. Either direction can destabilize diabetes control. Anyone with unexpected glycemic variability should have TSH checked.
How Thyroid Hormones Affect Glucose
| Mechanism | Effect of T3/T4 |
|---|---|
| Gastric emptying | Speeds up (hyper) / slows (hypo) |
| Carbohydrate absorption | Faster (hyper) / slower (hypo) |
| Hepatic gluconeogenesis | Increased (hyper) / decreased (hypo) |
| Glycogenolysis | Increased (hyper) / decreased (hypo) |
| Insulin clearance | Faster (hyper) / slower (hypo) |
| Peripheral insulin sensitivity | Decreased (hyper, net) / variable (hypo) |
| Beta-cell function | Stressed in hyper; preserved in mild hypo |
| Counterregulatory response (epinephrine, cortisol) | Heightened in hyper; blunted in severe hypo |
Hypothyroidism and Blood Sugar
- Slower postprandial absorption — late glucose peaks (2 to 4 hours after meals)
- Reduced insulin clearance — injected or endogenous insulin stays in circulation longer
- Lower hepatic glucose output — fasting glucose may run lower than expected
- Blunted counterregulatory hormones — hypoglycemia symptoms may be subtle
- Weight gain and fatigue — reduce adherence to exercise and meal planning
- Net effect: increased hypoglycemia risk; insulin requirements may fall
Hyperthyroidism and Blood Sugar
- Faster gastric emptying and absorption — sharp postprandial glucose spikes
- Increased hepatic gluconeogenesis and glycogenolysis — fasting hyperglycemia
- Faster insulin clearance — insulin acts for less time
- Increased peripheral insulin resistance
- Beta-cell stress — may unmask diabetes in susceptible patients
- DKA risk — in undiagnosed or poorly controlled type 1 diabetes
- Net effect: hyperglycemia; insulin requirements rise 30 to 50 percent
Glucose Patterns by Thyroid Status
| Pattern | Hypothyroid | Euthyroid | Hyperthyroid |
|---|---|---|---|
| Fasting glucose | Lower than usual | Stable | Higher than usual |
| Postprandial peak timing | Delayed (2 to 4 hr) | 1 to 2 hr | Earlier and higher |
| Hypoglycemia frequency | Increased | Stable | Decreased |
| Insulin requirements | Decreased | Stable | Increased 30 to 50% |
| A1C trajectory | Stable or falling | Stable | Rising |
| Glucose variability | Increased | Low | Markedly increased |
| DKA risk (T1D) | Lower | Stable | Increased |
How Often Should TSH Be Checked?
| Situation | TSH Frequency |
|---|---|
| Type 1 diabetes at diagnosis | At diagnosis, then every 1 to 2 years |
| Type 2 diabetes at diagnosis | If symptoms, otherwise every 1 to 2 years |
| Unexplained glucose variability | Promptly |
| New hypoglycemia in stable patient | Promptly |
| Pregnancy with diabetes | Each trimester |
| Postpartum (T1D) | 6 weeks and 6 months |
| Starting or changing thyroid medication | 6 to 8 weeks after change |
| New atrial fibrillation | Always |
| Lithium or amiodarone therapy | Every 6 months |
Hypoglycemia from Thyroid Disease — Patterns to Recognize
- Late evening or overnight lows in insulin users
- Symmetric lows after most meals
- Loss of typical adrenergic symptoms (tremor, sweating, palpitations) — autonomic blunting in severe hypothyroidism
- Patterns starting weeks to months after a viral illness (postpartum or de novo Hashimoto’s)
- Coincident weight gain, cold intolerance, constipation, fatigue
Hyperglycemia from Thyroid Disease — Patterns to Recognize
- Climbing A1C without dietary or activity change
- Sharp postprandial glucose spikes despite usual insulin dosing
- Need to escalate insulin doses 30 to 50 percent
- Coincident weight loss despite increased appetite
- New palpitations, heat intolerance, tremor, anxiety
- DKA episodes in previously well-controlled type 1 diabetes
Practical Medication Adjustments
| Scenario | Likely Insulin Adjustment |
|---|---|
| Starting levothyroxine for new hypothyroidism | Watch for hypoglycemia; reduce basal or sulfonylurea by 10 to 20% |
| Hyperthyroidism diagnosis (new Graves’) | Increase insulin 20 to 50% acutely; close CGM monitoring |
| After radioactive iodine for Graves’ | Reduce insulin as thyroid function falls; expect hypothyroidism eventually |
| Post-thyroidectomy | Lifelong levothyroxine; recalibrate insulin needs over weeks |
| Postpartum thyroiditis | Anticipate hyper followed by hypo phase; adjust insulin in stages |
Drug Interactions to Watch
- Beta-blockers used for hyperthyroidism may mask hypoglycemia awareness
- Levothyroxine taken with metformin or calcium loses absorption — separate by 4 hours
- Glucocorticoids (e.g., for thyroiditis flare) raise glucose substantially
- Amiodarone can cause both hypo- and hyperthyroidism and unpredictable glucose changes
- Immune checkpoint inhibitors (cancer therapy) commonly trigger autoimmune thyroid disease and rarely autoimmune diabetes
Monitoring During Thyroid Treatment Transitions
- Continuous glucose monitor (CGM) is highly useful during the first 2 to 3 months of treatment
- Recheck TSH 6 to 8 weeks after any thyroid medication change
- Reassess A1C every 3 months until stable
- Monitor lipid panel — improves with treatment of hypothyroidism
- Track weight; gradual reversal of weight gain or loss is expected
- Reassess hypoglycemia awareness, especially in type 1 diabetes
Special Situations
- Pregnancy: Thyroid demands rise; levothyroxine dose typically needs a 30 percent increase by 6 weeks. Insulin sensitivity falls in the third trimester.
- Postpartum thyroiditis: Common in T1D; biphasic hyper-then-hypo course over months. Glucose patterns can swing in both directions.
- Sick day management: Thyroid hormone is generally continued during acute illness; insulin doses are adjusted per sick-day rules.
- Surgery: Optimize thyroid function before elective surgery; severe untreated hypo- or hyperthyroidism is a perioperative risk.
When to See a Specialist
- Unexplained glucose variability despite usual care
- TSH abnormal on screening
- Recurrent hypoglycemia in a previously stable patient
- Sudden need for large insulin dose increases
- New atrial fibrillation or palpitations
- Pregnancy with type 1 diabetes
- Suspected autoimmune polyendocrine syndrome
Why This Matters
Thyroid status is one of the most powerful — and most overlooked — drivers of glucose variability. Identifying and treating thyroid disease can stabilize patterns that have frustrated patients and clinicians for years. See the diabetes and thyroid foundation, and for context on glucose targets see our A1C levels guide.
Related Reading
For specific conditions, see Hashimoto and type 1 diabetes, hypothyroidism and diabetes, and Graves disease and diabetes. Patient resources from the American Thyroid Association are at thyroid.org.
The Bottom Line
Thyroid hormones strongly influence blood sugar through gastric emptying, insulin clearance, and hepatic glucose production. Hypothyroidism tends to cause hypoglycemia and lower insulin needs; hyperthyroidism causes hyperglycemia and raises insulin requirements 30 to 50 percent. Either direction can destabilize a previously well-controlled patient. Anyone with unexplained glycemic variability — frequent lows, climbing A1C without dietary change, or sudden insulin sensitivity shifts — should have TSH checked. Treating thyroid disease restores glucose stability and is one of the highest-yield interventions in diabetes care.
